In populo

Epidemiology

Volumn 21, Issue 1, 2010, Pages 152-153

  Westreich, Daniel ^a   Pence, Brian W ^b   Turner, Abigail Norris ^c  

^a University of North Carolina at Chapel Hill   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; SMALLPOX VACCINE;

CLINICAL TRIAL; COMMUNITY DYNAMICS; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; HERD IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LANGUAGE; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; POPULATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PUBLIC HEALTH; RANDOM ERROR; SCIENCE; SCIENTIST; SHORT SURVEY; SMALLPOX; TREATMENT OUTCOME; TREATMENT RESPONSE; VACCINATION;

EPIDEMIOLOGY; HUMANS; TERMINOLOGY AS TOPIC;

EID: 73849093360     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181c1e92a     Document Type: Short Survey

References (18)

1. Lewis CT, Short C. A Latin Dictionary. Oxford, United Kingdom: Clarendon Press; 1879. Available at: http://www.perseus.tufts.edu/.
2. Liem DS, Waltuch TL, Eiseman B. Function of the ex-vivo pig liver perfused with human blood. Surg Forum. 1964;15:90-91.
3. Wikipedia. Ex vivo. Available at: http://en.wikipedia.org/wiki/Ex-vivo. Accessed 13 May, 2009.
4. The President's Council on Bioethics. Glossary (definition of "Ex vivo"). Available at: http://www.bioethics.gov/reports/white-paper/ glossary.html. Accessed 7 August, 2009.
5. National Institute of General Medical Sciences. The Chemistry of Health: Glossary. Available at: http://publications.nigms.nih.gov/chemhealth/glossary. html. Accessed 7 August, 2009.
6. Wikipedia. In silico. Available at: http://en.wikipedia.org/wiki/In- silico. Accessed 13 May, 2009.
7. Wikipedia. In papyro. Available at: http://en.wikipedia.org/wiki/In- papyro. Accessed 13 May, 2009.
8. PubMed Database. Available at: http://www.ncbi.nlm.nih.gov/pubmed/. Accessed 7, August 2009.
9. Tissue growth in vitro. Cal State J Med. 1911;9:355-356.
10. Perkins JA. Preliminary report of a method for estimating in vivo the germicidal activity of antiseptics. Ann Surg. 1918;68:241-244.
11. Hansen FG, Christensen BB, Atlung T. The initiator titration model: computer simulation of chromosome and minichromosome control. Res Microbiol. 1991;142:161-167.
12. John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000;16:601-606.
13. Committee on Infectious Diseases. American Academy of Pediatrics. Smallpox vaccine. Pediatrics. 2002;110:841-845.
14. Belshe RB, Graham BS, Keefer MC, et al. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network. JAMA. 1994;272:475-480.
15. Migasena S, Suntharasamai P, Pitisuttithum P, et al. AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization. AIDS Res Hum Retroviruses. 2000;16:655-663.
16. Pitisuttithum P, Nitayaphan S, Thongcharoen P, et al. Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J Infect Dis. 2003;188:219-227.
17. Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, Para MF. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis. 2005;191:654-665.
18. Pitisuttithum P, Gilbert P, Gurwith M, et al. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis. 2006;194:1661-1671.